<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-040625</identifier>
<setSpec>0034-9356</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Hemodynamic effects of levosimendan following cardiac surgery</dc:title>
<dc:description xml:lang="en">The hemodynamic effect of levosimendan was compared    to that of dobutamine in a trial enrolling 30 adults    undergoing scheduled cardiac surgery with cardiopulmonary    bypass. Fifteen patients were randomly assigned to    receive levosimendan in a single dose of 18 µg.kg-1 followed    in 15 to 20 minutes by start of infusion at a rate of 0.2    µg.kg-1min-1 for 24 hours (levosimendan group). Another    15 randomized patients received dobutamine infused at a    rate of 7.5 µg.kg-1min-1. Hemodynamic parameters were    measured before starting infusion of the drug and after 24    hours of treatment. Changes in the main hemodynamic    parameters were as follows.    In the levosimendan group heart rate (beats/min) was    87.15 (SD 10.22) at baseline and 87.91 (6.00) at 24 hours;    mean arterial pressure (mm Hg) was 83.96 (10.57) at baseline    and 86.41 (13.29) after 24 hours; cardiac index    (L/min/m2) was 2.21 (0.23) at baseline and 2.53 (0.35) at 24    hours; systemic vascular resistance (dyn/sec-1/cm-5) was    1436.74 (311.48) at baseline and 1378.35 (320.68) at 24    hours. In the dobutamine group heart rate (beats/min) was    84.28 (2.18) at baseline and 96.02 (9.10) after 24 hours;    mean arterial pressure (mm Hg) was 83.59 (9.05) at baseline    and 74.29 (6.33) at 24 hours; cardiac index (L/min/m2)    was 2.16 (0.28) at baseline and) 3.02 (0.34) at 24 hours; systemic    vascular resistance (dyn/sec-1/cm-5) was 1578.93    (334.88) at baseline and 1136.68 (158.60) at 24 hours. We    found that mean arterial pressure and both systemic and    pulmonary vascular resistance decreased significantly in    the levosimendan group (P&lt;0.05), but not in the dobutamine    group. On the other hand, both heart rate and cardiac    index increased in the levosimendan group only (P&lt;0.05).    We conclude that levosimendan improves hemodynamic    stability in patients who have undergone cardiac surgery    and that it is a good alternative for treating postoperative    low cardiac output syndromeThe hemodynamic effect of levosimendan was compared    to that of dobutamine in a trial enrolling 30 adults    undergoing scheduled cardiac surgery with cardiopulmonary    bypass. Fifteen patients were randomly assigned to    receive levosimendan in a single dose of 18 &amp;#956;g.kg-1 followed    in 15 to 20 minutes by start of infusion at a rate of 0.2    &amp;#956;g.kg-1min-1 for 24 hours (levosimendan group). Another    15 randomized patients received dobutamine infused at a    rate of 7.5 &amp;#956;g.kg-1min-1. Hemodynamic parameters were    measured before starting infusion of the drug and after 24    hours of treatment. Changes in the main hemodynamic    parameters were as follows.    In the levosimendan group heart rate (beats/min) was    87.15 (SD 10.22) at baseline and 87.91 (6.00) at 24 hours;    mean arterial pressure (mm Hg) was 83.96 (10.57) at baseline    and 86.41 (13.29) after 24 hours; cardiac index    (L/min/m2) was 2.21 (0.23) at baseline and 2.53 (0.35) at 24    hours; systemic vascular resistance (dyn/sec-1/cm-5) was    1436.74 (311.48) at baseline and 1378.35 (320.68) at 24    hours. In the dobutamine group heart rate (beats/min) was    84.28 (2.18) at baseline and 96.02 (9.10) after 24 hours;    mean arterial pressure (mm Hg) was 83.59 (9.05) at baseline and 74.29 (6.33) at 24 hours; cardiac index (L/min/m2) was 2.16 (0.28) at baseline and) 3.02 (0.34) at 24 hours; systemic vascular resistance (dyn/sec-1/cm-5) was 1578.93 (334.88) at baseline and 1136.68 (158.60) at 24 hours. We found that mean arterial pressure and both systemic and pulmonary vascular resistance decreased significantly in the levosimendan group (P&lt;0.05), but not in the dobutamine group. On the other hand, both heart rate and cardiac index increased in the levosimendan group only (P&lt;0.05). We conclude that levosimendan improves hemodynamic stability in patients who have undergone cardiac surgery and that it is a good alternative for treating postoperative low cardiac output syndrome</dc:description>
<dc:creator>Caruezo, V</dc:creator>
<dc:creator>Álvarez, J</dc:creator>
<dc:creator>Rodríguez, J</dc:creator>
<dc:creator>Pérez-Paz, J</dc:creator>
<dc:creator>Bascuas, B</dc:creator>
<dc:creator>Taboada, M</dc:creator>
<dc:creator>Ginesta, V</dc:creator>
<dc:creator>Bouzada, M</dc:creator>
<dc:creator>Campaña, O</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Se compararon 30 pacientes adultos sometidos a cirugía    cardiaca programada con circulación extracorpórea    al objeto de estudiar el efecto de la dobutamina y levosimendan    sobre la hemodinámica.    Quince pacientes recibieron levosimendan en dosis    bolus de 12 &amp;#956;g kg-1 en 15-20 min seguidos de una infusión    de 0,2 &amp;#956;g kg-1 min-1 durante 24 horas (grupo levosimendan).    Otros 15 enfermos recibieron una infusión de    dobutamina en dosis de 7,5 &amp;#956;g kg-1 min-1.    Los parámetros hemodinámicos fueron medidos antes    de comenzar la infusión del fármaco y a las 24 horas de    tratamiento.    La evolución de los principales parámetros hemodinámicos    es la siguiente:    Grupo dobutamina: Frecuencia cardiaca (latidos    /min) 87,15 ± 10,22 (basal) 87,91 ± 6,00 (24 horas); Presión    arterial media (mmHg) 83,96 ± 10,57 (basal) 86,41    ± 13,29 (24 horas); Índice cardiaco (l/min/m2): 2,21 ±    0,23 (basal) 2,53 ± 0,35 (24 horas); resistencias vasculares    periféricas (dyn seg-1cm-5): 1436,74 ± 311,48 (basal)    1378,35 ± 320,68 (24 horas).    Grupo levosimendan: Frecuencia cardiaca (latidos/    min) 84,28 ± 12,18 (basal) 96,02 ± 9,10 (24 horas); Presión    arterial media (mm Hg) 83,59 ± 9,05 (basal) 74,29 ±    6,33 (24 horas); Índice cardiaco (l/min/m2): 2,16 ± 0,28    (basal) 3,02 ± 0,34 (24 horas); resistencias vasculares    periféricas (dyn seg-1cm-5): 1578,93 ± 334,88 (basal)    1136,68 ± 158,60 (24 horas).    Encontramos que las resistencias vasculares y la presión    arterial media disminuyen de forma significativa    (p&lt;0,05) en el grupo levosimendan, pero no en el grupo    dobutamina y que la frecuencia cardiaca y el índice cardiaco aumentan en el grupo levosimendan pero no en el    grupo dobutamina. Concluimos que el levosimendan mejora la situación hemodinámica de estos pacientes y es una alternativa en el tratamiento del síndrome de bajo gasto postoperatorio</dc:description>
<dc:source>Rev Esp Anestesiol Reanim;52(7): 389-394, ago.-sept. 2005. tab, graf</dc:source>
<dc:identifier>ibc-040625</dc:identifier>
<dc:title xml:lang="es">Efectos hemodinámicos del levosimendan en el postoperatorio de pacientes sometidos a cirugía cardiaca</dc:title>
<dc:subject>^d6988^s22078</dc:subject>
<dc:subject>^d29646</dc:subject>
<dc:subject>^d5211</dc:subject>
<dc:subject>^d29623</dc:subject>
<dc:subject>^d2347^s22027</dc:subject>
<dc:subject>^d9392^s22021</dc:subject>
<dc:subject>^d6500</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d12161^s22073</dc:subject>
<dc:subject>^d12161^s22078</dc:subject>
<dc:subject>^d11622^s22057</dc:subject>
<dc:subject>^d28274^s22021</dc:subject>
<dc:subject>^d19210</dc:subject>
<dc:subject>^d6590^s22021</dc:subject>
<dc:subject>^d6988^s22073</dc:subject>
<dc:subject>^d10281^s22021</dc:subject>
<dc:subject>^d1821^s22021</dc:subject>
<dc:subject>^d2347^s22057</dc:subject>
<dc:subject>^d4341^s22073</dc:subject>
<dc:subject>^d11623</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d11622^s22027</dc:subject>
<dc:subject>^d2357^s22078</dc:subject>
<dc:subject>^d4341^s22078</dc:subject>
<dc:subject>^d22780</dc:subject>
<dc:subject>^d2357^s22073</dc:subject>
<dc:subject>^d28607</dc:subject>
<dc:subject>^d15057^s22021</dc:subject>
<dc:subject>^d6493^s22021</dc:subject>
<dc:type>article</dc:type>
<dc:date>200509</dc:date>
</metadata>
</record>
</ibecs-document>
